ENTRY       D07907                      Drug
NAME        Erlotinib (INN)
FORMULA     C22H23N3O4
EXACT_MASS  393.1689
MOL_WEIGHT  393.4357
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
               DG03162  EGFR inhibitor
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: L01EB02
            Chemical structure group: DG00711
            Product (DG00711): D04023<JP/US>
EFFICACY    Antineoplastic, Receptor tyrosine kinase inhibitor
TARGET      EGFR [HSA:1956] [KO:K04361]
  PATHWAY   hsa04010(1956)  MAPK signaling pathway
            hsa04012(1956)  ErbB signaling pathway
            hsa05200(1956)  Pathways in cancer
            hsa05212(1956)  Pancreatic cancer
            hsa05223(1956)  Non-small cell lung cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP1A2 [HSA:1544]
INTERACTION  
STR_MAP     map07045  Antineoplastics - protein kinase inhibitors
OTHER_MAP   map01521  EGFR tyrosine kinase inhibitor resistance
            map04976  Bile secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
                 L01EB02 Erlotinib
                  D07907  Erlotinib (INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03162  EGFR inhibitor
                 DG00711  Erlotinib
                  D07907  Erlotinib
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00711  Erlotinib
                D07907  Erlotinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00711  Erlotinib
                 D07907  Erlotinib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                EGFR
                 D07907  Erlotinib (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07907
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03162  EGFR inhibitor
                 DG00711  Erlotinib
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00711  Erlotinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00711  Erlotinib
DBLINKS     CAS: 183321-74-6
            PubChem: 96024603
            ChEBI: 114785
            PDB-CCD: AQ4
            LigandBox: D07907
ATOM        29
            1   C8x C    13.1858  -13.0551
            2   N5x N    13.1858  -14.4518
            3   C8y C    14.5127  -15.1501
            4   C8y C    15.6999  -14.4518
            5   C8y C    15.6999  -13.0551
            6   N5x N    14.5127  -12.3568
            7   C8x C    16.8871  -15.1501
            8   C8y C    18.0743  -14.4518
            9   C8y C    18.0743  -13.0551
            10  C8x C    16.8871  -12.3568
            11  N1b N    14.5127  -16.4770
            12  C8y C    15.6999  -17.1754
            13  C8x C    15.6999  -18.5720
            14  C8y C    16.8871  -19.3402
            15  C8x C    18.0743  -18.5720
            16  C8x C    18.0743  -17.1754
            17  C8x C    16.8871  -16.4770
            18  O2a O    19.2615  -12.3568
            19  C1b C    20.5185  -13.0551
            20  C1b C    21.7057  -12.3568
            21  O2a O    22.8929  -13.0551
            22  C1a C    24.1499  -12.3568
            23  O2a O    19.2615  -15.1501
            24  C1b C    20.5185  -14.4518
            25  C1b C    21.7057  -15.1501
            26  O2a O    22.8929  -14.4518
            27  C1a C    24.1499  -15.1501
            28  C3b C    16.8868  -20.7199
            29  C3a C    16.8868  -22.1199
BOND        31
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 2
            7     4   7 2
            8     7   8 1
            9     8   9 2
            10    9  10 1
            11    5  10 2
            12    3  11 1
            13   11  12 1
            14   12  13 2
            15   13  14 1
            16   14  15 2
            17   15  16 1
            18   16  17 2
            19   12  17 1
            20    9  18 1
            21   18  19 1
            22   19  20 1
            23   20  21 1
            24   21  22 1
            25    8  23 1
            26   23  24 1
            27   24  25 1
            28   25  26 1
            29   26  27 1
            30   14  28 1
            31   28  29 3
///
